Your browser doesn't support javascript.
loading
SARS-CoV-2-specific CD4+ T cell longevity correlates with Th17-like phenotype.
Terahara, Kazutaka; Sato, Takashi; Adachi, Yu; Tonouchi, Keisuke; Onodera, Taishi; Moriyama, Saya; Sun, Lin; Takano, Tomohiro; Nishiyama, Ayae; Kawana-Tachikawa, Ai; Matano, Tetsuro; Matsumura, Takayuki; Shinkai, Masaharu; Isogawa, Masanori; Takahashi, Yoshimasa.
Afiliación
  • Terahara K; Research Center for Drug and Vaccine Development, National Institute of Infectious Diseases, Tokyo 162-8640, Japan.
  • Sato T; Tokyo Shinagawa Hospital; Tokyo, 140-8522, Japan.
  • Adachi Y; Research Center for Drug and Vaccine Development, National Institute of Infectious Diseases, Tokyo 162-8640, Japan.
  • Tonouchi K; Research Center for Drug and Vaccine Development, National Institute of Infectious Diseases, Tokyo 162-8640, Japan.
  • Onodera T; Department of Life Science and Medical Bioscience, Waseda University, Tokyo, 162-8480, Japan.
  • Moriyama S; Research Center for Drug and Vaccine Development, National Institute of Infectious Diseases, Tokyo 162-8640, Japan.
  • Sun L; Research Center for Drug and Vaccine Development, National Institute of Infectious Diseases, Tokyo 162-8640, Japan.
  • Takano T; Research Center for Drug and Vaccine Development, National Institute of Infectious Diseases, Tokyo 162-8640, Japan.
  • Nishiyama A; Research Center for Drug and Vaccine Development, National Institute of Infectious Diseases, Tokyo 162-8640, Japan.
  • Kawana-Tachikawa A; Research Center for Drug and Vaccine Development, National Institute of Infectious Diseases, Tokyo 162-8640, Japan.
  • Matano T; AIDS Research Center, National Institute of Infectious Diseases, Tokyo, 162-8640, Japan.
  • Matsumura T; AIDS Research Center, National Institute of Infectious Diseases, Tokyo, 162-8640, Japan.
  • Shinkai M; Research Center for Drug and Vaccine Development, National Institute of Infectious Diseases, Tokyo 162-8640, Japan.
  • Isogawa M; Tokyo Shinagawa Hospital; Tokyo, 140-8522, Japan.
  • Takahashi Y; Research Center for Drug and Vaccine Development, National Institute of Infectious Diseases, Tokyo 162-8640, Japan.
iScience ; 25(9): 104959, 2022 Sep 16.
Article en En | MEDLINE | ID: mdl-35992306
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: IScience Año: 2022 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: IScience Año: 2022 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Estados Unidos